Absci receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Absci Corp (ABSI)
Absci Corp stock price, this page displays NASDAQ ABSI stock exchange data. View the ABSI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Absci Corp real time stock price chart below.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABSI quote. (ISIN: US00091E1091)
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABSI quote. (ISIN: US00091E1091)
2.885
-0.125(-4.15%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.800
3.110
52 wk Range
2.010
5.228
ABSI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.8003.110
52 wk Range
2.0105.228
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABSI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
8.046
Upside
+178.88%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Absci receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Absci Corp For: 24 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Absci Corp Earnings Call Summary for Q4/2025
- Q4 2025 EPS of -$0.20 missed forecast of -$0.18 by 11%; revenue of $700K fell 49% short of $1.38M estimate, triggering 1.54% stock decline.
- R&D expenses surged 37.5% YoY to $25.3M, reflecting increased investment in clinical pipeline, particularly ABS-201 program development.
- Company maintains strong cash position of $144.3M as of Dec 31, 2025, projected to fund operations through 2028 despite revenue shortfall.
- Forward guidance remains cautious with EPS forecast at -$0.18 for upcoming quarters; executives emphasize ABS-201 clinical trial progress as growth driver.
- Stock trading at $2.885 near 52-week low with beta of 2.13, indicating high volatility; InvestingPro suggests potential overvaluation concerns.
Last Updated: 25-03-2026, 03:20 am
Read Full TranscriptCompare ABSI to Peers and Sector
Metrics to compare | ABSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | −4.2x | −0.4x | |
PEG Ratio | −1.00 | −0.18 | 0.00 | |
Price/Book | 2.3x | 3.0x | 2.6x | |
Price / LTM Sales | 158.8x | 22.4x | 3.1x | |
Upside (Analyst Target) | 199.0% | 93.6% | 58.5% | |
Fair Value Upside | Unlock | 2.1% | 9.2% | Unlock |
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.046
(+178.88% Upside)
Earnings
Latest Release
24-03-2026
EPS / Forecast
-0.20 / -0.18
Revenue / Forecast
700K / 1.38M
FAQ
What Is the Absci (ABSI) Stock Price Today?
The Absci stock price today is 2.885.
What Stock Exchange Does Absci Trade On?
Absci is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Absci?
The stock symbol for Absci is "ABSI."
What Is the Absci Market Cap?
As of today, Absci market cap is 438.410M.
What Is Absci's Earnings Per Share (TTM)?
The Absci EPS (TTM) is -0.897.
When Is the Next Absci Earnings Date?
Absci will release its next earnings report on 19-05-2026.
From a Technical Analysis Perspective, Is ABSI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Absci Stock Split?
Absci has split 0 times.
How Many Employees Does Absci Have?
Absci has 157 employees.
What is the current trading status of Absci (ABSI)?
As of 25-03-2026, Absci (ABSI) is trading at a price of 2.885, with a previous close of 3.010. The stock has fluctuated within a day range of 2.800 to 3.110, while its 52-week range spans from 2.010 to 5.228.
What Is Absci (ABSI) Price Target According to Analysts?
The average 12-month price target for Absci is USD8.046, with a high estimate of USD10 and a low estimate of USD4.32. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +178.88% Upside potential.
What Is the ABSI Premarket Price?
ABSI's last pre-market stock price is 2.870. The pre-market share volume is 3,35,850.000, and the stock has decreased by -0.140, or -4.650%.
What Is the ABSI After Hours Price?
ABSI's last after hours stock price is 2.680, the stock has decreased by -0.330, or -10.960%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.